Literature DB >> 15305858

Disruption of the retinoid signalling pathway causes a deposition of amyloid beta in the adult rat brain.

Jonathan P T Corcoran1, Po Lin So, Malcolm Maden.   

Abstract

We have disrupted the retinoid signalling pathway in adult rats by a dietary deficiency of vitamin A. After 1 year of this dietary deficiency, there was a deposition of amyloid beta in the cerebral blood vessels. There is a downregulation of retinoic acid receptor alpha in the forebrain neurons of the retinoid-deficient rats and a loss of choline acetyl transferase expression, which precedes amyloid beta deposition. In neocortex of pathology samples of patients with Alzheimer's disease, the same retinoic acid receptor alpha deficit in the surviving neurons was observed. We have identified the retinoid-synthesizing enzymes involved in this process, retinaldehyde dehydrogenase-2 and class IV alcohol dehydrogenase, only the former is downregulated in patients with Alzheimer's disease. This suggests that retinoids are important for the maintenance of the adult nervous system and their loss may in part play a role in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15305858     DOI: 10.1111/j.1460-9568.2004.03563.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  59 in total

Review 1.  Molecular Signaling Mechanisms of Natural and Synthetic Retinoids for Inhibition of Pathogenesis in Alzheimer's Disease.

Authors:  Mrinmay Chakrabarti; Alexander J McDonald; J Will Reed; Melissa A Moss; Bhaskar C Das; Swapan K Ray
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

2.  Working memory deficits in retinoid X receptor gamma-deficient mice.

Authors:  Marta Wietrzych; Hamid Meziane; Anne Sutter; Norbert Ghyselinck; Paul F Chapman; Pierre Chambon; Wojciech Krezel
Journal:  Learn Mem       Date:  2005-05-16       Impact factor: 2.460

3.  Why should plasma transthyretin become a routine screening tool in elderly persons?

Authors:  Y Ingenbleek
Journal:  J Nutr Health Aging       Date:  2009-08       Impact factor: 4.075

4.  Ethanol impairs activation of retinoic acid receptors in cerebellar granule cells in a rodent model of fetal alcohol spectrum disorders.

Authors:  Ambrish Kumar; Chandra K Singh; Donald D DiPette; Ugra S Singh
Journal:  Alcohol Clin Exp Res       Date:  2010-03-01       Impact factor: 3.455

5.  Retinoid signaling alterations in amyotrophic lateral sclerosis.

Authors:  Christi L Kolarcik; Robert Bowser
Journal:  Am J Neurodegener Dis       Date:  2012-07-23

Review 6.  Obesity as a risk factor for Alzheimer's disease: the role of adipocytokines.

Authors:  Liliana Letra; Isabel Santana; Raquel Seiça
Journal:  Metab Brain Dis       Date:  2014-02-20       Impact factor: 3.584

Review 7.  All-trans retinoic acid as a novel therapeutic strategy for Alzheimer's disease.

Authors:  Hyun-Pil Lee; Gemma Casadesus; Xiongwei Zhu; Hyoung-gon Lee; George Perry; Mark A Smith; Katarzyna Gustaw-Rothenberg; Alan Lerner
Journal:  Expert Rev Neurother       Date:  2009-11       Impact factor: 4.618

8.  Retinoic acid-elicited RARα/RXRα signaling attenuates Aβ production by directly inhibiting γ-secretase-mediated cleavage of amyloid precursor protein.

Authors:  Arun Kapoor; Bo-Jeng Wang; Wen-Ming Hsu; Ming-Yun Chang; Shu-Mei Liang; Yung-Feng Liao
Journal:  ACS Chem Neurosci       Date:  2013-04-15       Impact factor: 4.418

9.  Retinoic acid attenuates beta-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model.

Authors:  Yun Ding; Aimin Qiao; Ziqing Wang; J Shawn Goodwin; Eun-Sook Lee; Michelle L Block; Matthew Allsbrook; Michael P McDonald; Guo-Huang Fan
Journal:  J Neurosci       Date:  2008-11-05       Impact factor: 6.167

10.  Upregulation of CRABP1 in human neuroblastoma cells overproducing the Alzheimer-typical Abeta42 reduces their differentiation potential.

Authors:  Markus Uhrig; Peter Brechlin; Olaf Jahn; Yuri Knyazev; Annette Weninger; Laura Busia; Kamran Honarnejad; Markus Otto; Tobias Hartmann
Journal:  BMC Med       Date:  2008-12-16       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.